2月21日 - ** 基因测序设备制造商IlluminaILMN.O股价下跌2.7%，至94.6美元
** 伯恩斯坦分析师称，罗氏公司ROG.S的新型基因测序设备 旨在解码癌症、免疫紊乱和神经退行性疾病等疾病，其表现优于Illumina的设备。
* * ROG公司于本周 四 发布了该设备 (link) ，其基因测序功能可提供对 遗传学、基因组学和细胞生物学的详细见解。
** 消息发布后，ILMN 股价周四收盘下跌 5.6
** 伯恩斯坦对 ROG 设备的准确性提出质疑，但表示它在某些应用中可能对 ILMN 构成严重威胁。
** ILMN 在过去 12 个月中下跌了 24.8
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.